Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jingsai Gu, Yishuang Xu, Dihao Hua & Zhen Chen. (2023) Role of Artesunate in Autoimmune Diseases and Signaling Pathways. Immunotherapy 15:14, pages 1183-1193.
Read now
Read now
Xun Zhao, DeJun Cui, WenQiang Yuan, Chen Chen & Qi Liu. (2022) Berberine represses Wnt/β-catenin pathway activation via modulating the microRNA-103a-3p/Bromodomain-containing protein 4 axis, thereby refraining pyroptosis and reducing the intestinal mucosal barrier defect induced via colitis. Bioengineered 13:3, pages 7392-7409.
Read now
Read now
Articles from other publishers (9)
Kaidi Xie, Zhen Li, Yang Zhang, Hao Wu, Tong Zhang & Wen Wang. (2024) Artemisinin and its derivatives as promising therapies for autoimmune diseases. Heliyon, pages e27972.
Crossref
Crossref
Xu Gao, Xian Lin, Qingwen Wang & Jian Chen. (2023) Artemisinins: Promising drug candidates for the treatment of autoimmune diseases. Medicinal Research Reviews 44:2, pages 867-891.
Crossref
Crossref
Jiabin Wu, Ke Li, Muge Zhou, Haoyang Gao, Wenhong Wang & Weihua Xiao. (2024) Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway. Journal of Pharmaceutical Analysis.
Crossref
Crossref
Ya Tao, Lei Xu, Xiaopan Liu, Peijia Wang, Simin Wei, Yinmo Huang, Wenyi Gu, Ruonan Bo, Mingjiang Liu, Jie Yu & Jingui Li. (2024) Chitosan-coated artesunate protects against ulcerative colitis via STAT6-mediated macrophage M2 polarization and intestinal barrier protection. International Journal of Biological Macromolecules 254, pages 127680.
Crossref
Crossref
Tommaso Innocenti, Elisabetta Bigagli, Erica Nicola Lynch, Andrea Galli & Gabriele Dragoni. (2023) MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?. Inflammatory Bowel Diseases 29:2, pages 308-323.
Crossref
Crossref
Ioanna Aggeletopoulou, Athanasia Mouzaki, Konstantinos Thomopoulos & Christos Triantos. (2023) miRNA Molecules—Late Breaking Treatment for Inflammatory Bowel Diseases?. International Journal of Molecular Sciences 24:3, pages 2233.
Crossref
Crossref
Zhancheng Lin, Lu Lu & Lingyu Zhu. (2023) Molecular Mechanism of Qingchang Suppository in the Treatment of Ulcerative
Colitis Based on Network Pharmacology. Letters in Drug Design & Discovery 20:1, pages 71-76.
Crossref
Crossref
Sophie Vieujean, Bénédicte Caron, Vincent Haghnejad, Jean-Yves Jouzeau, Patrick Netter, Anne-Charlotte Heba, Ndeye Coumba Ndiaye, David Moulin, Guillermo Barreto, Silvio Danese & Laurent Peyrin-Biroulet. (2022) Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. International Journal of Molecular Sciences 23:14, pages 7611.
Crossref
Crossref
Feifei Qiu, Junfeng Liu, Xiumei Mo, Huazhen Liu, Yuchao Chen & Zhenhua Dai. (2021) Immunoregulation by Artemisinin and Its Derivatives: A New Role for Old Antimalarial Drugs. Frontiers in Immunology 12.
Crossref
Crossref